Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer
Open Access
- 1 January 2014
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Pharmacology
- Vol. 3 (4) , 120-139
Abstract
Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancerKeywords
This publication has 244 references indexed in Scilit:
- Upregulation of miR‐153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancerThe Prostate, 2012
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyCancer, 2012
- PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate CancerThe American Journal of Pathology, 2012
- Identification of the human testis protein phosphatase 1 interactomeBiochemical Pharmacology, 2011
- Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cellsMolecular Nutrition & Food Research, 2011
- Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcriptionProgress in Biophysics and Molecular Biology, 2010
- Inhibition of p21‐activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cellsThe Prostate, 2010
- Docking Motif-Guided Mapping of the Interactome of Protein Phosphatase-1Chemistry & Biology, 2009
- Identification and functional characterization of a PP1-binding site in BRCA1Biochemical and Biophysical Research Communications, 2007
- Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate CancerThe Prostate, 2004